Overview

Brain Imaging: Cocaine Effects & Medication Development - 5

Status:
Withdrawn
Trial end date:
1995-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Collaborators:
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Treatments:
Cocaine